We are live on ! Find out more
HLTH

Cue Health Inc. Common Stock

Delisted

HLTH was delisted on the 5th of June, 2024.

63 hedge funds and large institutions have $9.83M invested in Cue Health Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,250% more call options, than puts

Call options by funds: $87K | Put options by funds: $2K

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

13% less funds holding

Funds holding: 7263 (-9)

50% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 14

57% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 21

66% less capital invested

Capital invested by funds: $28.6M → $9.83M (-$18.8M)

Holders
63
Holders Change
-9
Holders Change %
-12.5%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
7
Increased
9
Reduced
21
Closed
14
Calls
$87K
Puts
$2K
Net Calls
+$85K
Net Calls Change
-$142K
Name Holding Trade Value Shares
Change
Change in
Stake
Squarepoint
26
Squarepoint
New York
$8.73K -$2.71K -8,168 -13%
TRCT
27
Tower Research Capital (TRC)
New York
$8.24K +$5.13K +15,449 +44%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$8.01K +$1 +3 +0%
Morgan Stanley
29
Morgan Stanley
New York
$6.66K -$6.8K -20,496 -33%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$6.31K -$13.5K -40,726 -51%
MCM
31
Manchester Capital Management
Vermont
$5.57K
AF
32
Allworth Financial
California
$5.04K -$22.9K -69,000 -69%
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$5K -$7.63K -22,992 -39%
VF
34
Virtu Financial
New York
$5K +$10.2K +30,840 New
AI
35
Alphabet Inc
California
$4.32K
MG
36
Marex Group
$4.3K +$8.79K +26,487 New
Two Sigma Investments
37
Two Sigma Investments
New York
$3.37K -$15.1K -45,389 -69%
PAG
38
Private Advisor Group
New Jersey
$3.25K
CNWM
39
Clay Northam Wealth Management
California
$2.7K
MCM
40
Morton Capital Management
California
$2.44K
ANTB
41
AMG National Trust Bank
Colorado
$2.34K
Ameriprise
42
Ameriprise
Minnesota
$2.31K -$5.35K -16,117 -53%
EWG
43
Executive Wealth Group
Washington
$2.29K
Commonwealth Equity Services
44
Commonwealth Equity Services
Massachusetts
$2K -$1.36K -4,104 -26%
Ohio Public Employees Retirement System (OPERS)
45
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.02K -$498 -1,500 -19%
Bank of America
46
Bank of America
North Carolina
$825 -$794 -2,392 -32%
Federated Hermes
47
Federated Hermes
Pennsylvania
$805 +$1.64K +4,953 New
Wells Fargo
48
Wells Fargo
California
$668 +$13 +39 +1%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$651
Qube Research & Technologies (QRT)
50
Qube Research & Technologies (QRT)
United Kingdom
$625 -$4.45K -13,419 -78%

HLTH Hedge Fund Activity: Q4 2023 in Review

63 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cue Health Inc. Common Stock (HLTH) for Q4 2023, worth a combined $9.83M — down 66% from $28.6M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of HLTH and 7 opened new positions — a net loss of 7 holders — while 21 trimmed existing stakes and 9 added.

The largest buyer was Goldman Sachs, adding an estimated $1.29M. The largest seller was Johnson & Johnson, exiting entirely with an estimated $2.45M sold.

  • 63 institutional investors held Cue Health Inc. Common Stock (HLTH) as of Q4 2023, down from 72 in Q3 2023.
  • Funds reported $9.83M of Cue Health Inc. Common Stock stock for Q4 2023, down 66% quarter-over-quarter.
  • 7 funds opened new Cue Health Inc. Common Stock positions in Q4 2023 and 14 closed out, a net change of -7 holders.
  • The largest Cue Health Inc. Common Stock buyer in Q4 2023 was Goldman Sachs, an estimated $1.29M added.
  • The largest Cue Health Inc. Common Stock seller in Q4 2023 was Johnson & Johnson, an estimated $2.45M sold.

Based on aggregated 13F filings for Q4 2023.